These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12907068)

  • 1. [Ciprofloxacin after clinical failure of beta-lactam antibiotics in children with salmonellosis].
    Moulin F; Sauvé-Martin H; Marc E; Lorrot MM; Soulier M; Ravilly S; Raymond J; Gendrel D
    Arch Pediatr; 2003 Jul; 10(7):608-14. PubMed ID: 12907068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children.
    Leibovitz E; Janco J; Piglansky L; Press J; Yagupsky P; Reinhart H; Yaniv I; Dagan R
    Pediatr Infect Dis J; 2000 Nov; 19(11):1060-7. PubMed ID: 11099086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of pefloxacin after failure of initial antibiotic treatment in children with severe salmonellosis.
    Gendrel D; Raymond J; Legall MA; Bergeret M; Badoual J
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):209-11. PubMed ID: 8389706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
    Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Clinically Isolated Antibiotic-Resistant Salmonella Typhimurium Exposed to Subinhibitory Concentrations of Ceftriaxone and Ciprofloxacin.
    Kim J; Ahn J
    Microb Drug Resist; 2017 Dec; 23(8):949-957. PubMed ID: 28486078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Failure of the treatment with antibiotics in severe Salmonella infections in children and use of quinolones].
    Moulin F; Raymond J; Bergeret M; Iniguez JL; Habib F; Chemillier-Truong M; Legall MA; Badoual J; Gendrel D
    Arch Pediatr; 1995 Apr; 2(4):317-23. PubMed ID: 7780538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children.
    Dutta P; Mitra U; Dutta S; De A; Chatterjee MK; Bhattacharya SK
    Indian J Med Res; 2001 Jun; 113():210-3. PubMed ID: 11816954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial drug resistance in non-typhoidal salmonellas from humans in England and Wales in 1999: decrease in multiple resistance in Salmonella enterica serotypes Typhimurium, Virchow, and Hadar.
    Threlfall EJ; Ward LR; Skinner JA; Graham A
    Microb Drug Resist; 2000; 6(4):319-25. PubMed ID: 11272261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with ciprofloxacin in children with typhoid fever.
    Thomsen LL; Paerregaard A
    Scand J Infect Dis; 1998; 30(4):355-7. PubMed ID: 9817514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Typing of extended-spectrum beta-lactamase-producing Salmonella typhimurium strains isolated in a pediatric unit].
    Mhand RA; Soukri A; Amarouch H; Mdaghri NE; Benbachir M
    Sante; 1999; 9(6):341-4. PubMed ID: 10705312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis.
    Salam MA; Dhar U; Khan WA; Bennish ML
    Lancet; 1998 Aug; 352(9127):522-7. PubMed ID: 9716056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative penicillin-binding protein involved in Salmonella relapses following ceftriaxone therapy.
    Castanheira S; López-Escarpa D; Pucciarelli MG; Cestero JJ; Baquero F; García-Del Portillo F
    EBioMedicine; 2020 May; 55():102771. PubMed ID: 32344200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution and transmission of a conjugative plasmid encoding both ciprofloxacin and ceftriaxone resistance in Salmonella.
    Chen K; Chan EWC; Chen S
    Emerg Microbes Infect; 2019; 8(1):396-403. PubMed ID: 30896347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of salmonellosis and shigellosis with the new quinolones].
    Biron F; Boibieux A; Tigaud S; Peyramond D
    Pathol Biol (Paris); 1990 Nov; 38(9):894-8. PubMed ID: 2277722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
    BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone-resistant salmonella infection acquired by a child from cattle.
    Fey PD; Safranek TJ; Rupp ME; Dunne EF; Ribot E; Iwen PC; Bradford PA; Angulo FJ; Hinrichs SH
    N Engl J Med; 2000 Apr; 342(17):1242-9. PubMed ID: 10781620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro activity of fluoroquinolones and oral beta lactam antibiotics against clinical isolates of Escherichia coli].
    Gómez-Martínez J; Marco F; Mensa J; Espasa M; Martínez JA; Jiménez de Anta MT
    Rev Esp Quimioter; 1999 Mar; 12(1):54-7. PubMed ID: 10209063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in antimicrobial susceptibility of Salmonella Typhi from North India (2001-2012).
    Singhal L; Gupta PK; Kale P; Gautam V; Ray P
    Indian J Med Microbiol; 2014; 32(2):149-52. PubMed ID: 24713900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroral ciprofloxacin therapy impairs the generation of a protective immune response in a mouse model for Salmonella enterica serovar Typhimurium diarrhea, while parenteral ceftriaxone therapy does not.
    Endt K; Maier L; Käppeli R; Barthel M; Misselwitz B; Kremer M; Hardt WD
    Antimicrob Agents Chemother; 2012 May; 56(5):2295-304. PubMed ID: 22354292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive Salmonella Infections at Multiple Surveillance Sites in the Democratic Republic of the Congo, 2011-2014.
    Kalonji LM; Post A; Phoba MF; Falay D; Ngbonda D; Muyembe JJ; Bertrand S; Ceyssens PJ; Mattheus W; Verhaegen J; Barbé B; Kuijpers L; Van Geet C; Lunguya O; Jacobs J
    Clin Infect Dis; 2015 Nov; 61 Suppl 4():S346-53. PubMed ID: 26449951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.